Rate of change in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view.

MedStar author(s):
Citation: Journal of Hypertension. 30(9):1690-6, 2012 Sep.PMID: 22895014Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Editorial | Meta-AnalysisSubject headings: *Carotid Arteries/pa [Pathology] | *Tunica Intima/pa [Pathology] | Atherosclerosis/pa [Pathology] | Humans | Risk FactorsYear: 2012Local holdings: Available online from MWHC library: 1997 - presentISSN:
  • 0263-6352
Name of journal: Journal of hypertensionAbstract: Whether a change in the rate of carotid intima-media thickness (CIMT) over time that is induced by a pharmaceutical intervention can be directly translated into change in future cardiovascular disease risk is an important issue. As this biomarker is increasingly used as primary outcome in many trials of the evaluation of novel cardiovascular treatments, this has become an important topic in cardiovascular drug development. Two recent meta-analyses using aggregated data from publication have attempted to address the issue. In our view both analyses suffer from considerable flaws. Flaws include the misuse of the concept of the atherosclerosis, pooling of trials carried out with treatments of heterogeneous efficacy and in patients, who had very different risk profiles; pooling of measurements from a wide variety of methodologies that shared a common name, 'CIMT'; lack of power for detecting relationships using meta-regression techniques, and lastly, the ecologic fallacy. In this article, we discuss the concerns in more detail and offer strategies to get a valid answer on whether therapy-induced change in CIMT indeed relates to change in vascular risk.All authors: Baldassarre D, Bots ML, den Ruijter HM, Grobbee DE, Kastelein JJ, O'Leary DH, Peters SA, Revkin JH, Stein JH, Taylor AJ, Tegeler CHFiscal year: FY2013Date added to catalog: 2013-09-17
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 22895014 Available 22895014

Available online from MWHC library: 1997 - present

Whether a change in the rate of carotid intima-media thickness (CIMT) over time that is induced by a pharmaceutical intervention can be directly translated into change in future cardiovascular disease risk is an important issue. As this biomarker is increasingly used as primary outcome in many trials of the evaluation of novel cardiovascular treatments, this has become an important topic in cardiovascular drug development. Two recent meta-analyses using aggregated data from publication have attempted to address the issue. In our view both analyses suffer from considerable flaws. Flaws include the misuse of the concept of the atherosclerosis, pooling of trials carried out with treatments of heterogeneous efficacy and in patients, who had very different risk profiles; pooling of measurements from a wide variety of methodologies that shared a common name, 'CIMT'; lack of power for detecting relationships using meta-regression techniques, and lastly, the ecologic fallacy. In this article, we discuss the concerns in more detail and offer strategies to get a valid answer on whether therapy-induced change in CIMT indeed relates to change in vascular risk.

English

Powered by Koha